The latest Investing Matters Podcast with Jean Roche, Co-Manager of Schroder UK Mid Cap Investment Trust has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksKerry Regulatory News (KYGA)

Share Price Information for Kerry (KYGA)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 78.10
Bid: 77.80
Ask: 78.30
Change: -1.25 (-1.58%)
Spread: 0.50 (0.643%)
Open: 77.80
High: 78.10
Low: 77.60
Prev. Close: 79.35
KYGA Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Transaction in Own Shares

7 Dec 2023 07:00

RNS Number : 9342V
Kerry Group PLC
07 December 2023
 

 

07 December 2023

LEI: 635400TLVVBNXLFHWC59

 

KERRY GROUP PLC

Regulatory Announcement

TRANSACTION IN OWN SHARES

Kerry Group plc ("Kerry" or the "Company") announces that on Wednesday, December 06, 2023  it purchased the following number of its A ordinary shares of ?0.125 each (the "Ordinary Shares") on Euronext Dublin from J&E Davy. The Ordinary Shares purchased will be cancelled.

Euronext Dublin

Number of Ordinary Shares purchased: 

35,000

Highest price paid per Ordinary Share:

?75.4000

Lowest price paid per Ordinary Share:

?74.8800

Volume weighted average price paid per Ordinary Share:

?75.1029

 

The Ordinary Shares purchased form part of Kerry's intention to buyback Ordinary Shares of a total value of up to ?300 million in the period up to 30 April 2024 ("Buyback Programme"). This Buyback Programme was launched on 1 November 2023 and formally commenced on that date.

Following settlement of the above transactions and subsequent share cancellation Kerry will have 176,104,787 Ordinary Shares in issue (excluding treasury shares).

In accordance with Article 5(1)(b) of Regulation (EU) No 596/2014 (the "Market Abuse Regulation") (including as it forms part of retained EU law in the United Kingdom ('UK') from time to time and, where relevant, pursuant to the UK's European Union (Withdrawal) Act 2018 and the UK's Market Abuse (Amendment) (EU Exit) Regulations 2019), a detailed breakdown of individual trades made by J&E Davy as riskless principal on behalf of Kerry on Euronext Dublin as part of the Buyback Programme for subsequent repurchase by the Company is scheduled to this announcement.

 

CONTACT INFORMATION

 

 

 

 

Group Secretary

 

 

 

Ronan Deasy

 

 

 

+353 66 7182000 | TraleeCoSec@kerry.ie

 

 

 

 

Website

 

 

 

www.kerry.com

 

 

 

 

 

 

Issuer name:

Kerry Group plc

 

 

LEI

635400TLVVBNXLFHWC59

 

ISIN:

IE0004906560

 

Intermediary name:

J&E Davy

 

Intermediary code:

DAVYIE21

 

Time zone:

GMT

 

Currency:

EUR

 

 

Aggregated Information

 

 

Trading venue

Currency

Volume Weighted Average Price

Aggregated volume

 

Euronext Dublin

EUR

?75.1029

35,000

 

 

Euronext Dublin

 

 

Number ofShares

Price per Share (EUR)

Trading Venue

Time of Transaction

MatchID

1000

75.24

Euronext Dublin

08:16:11

00041509628TRLO0-1

5000

75.09

Euronext Dublin

08:32:30

00041509827TRLO0-1

2500

75.22

Euronext Dublin

08:54:59

00041510074TRLO0-1

2500

75.12

Euronext Dublin

10:42:28

00041511395TRLO0-1

2000

75.36

Euronext Dublin

11:48:18

00041512211TRLO0-1

1500

75.36

Euronext Dublin

11:50:02

00041512223TRLO0-1

1500

75.4

Euronext Dublin

12:05:27

00041512374TRLO0-1

2000

75.34

Euronext Dublin

12:14:21

00041512497TRLO0-1

1000

74.92

Euronext Dublin

13:35:01

00041513656TRLO0-1

2000

75

Euronext Dublin

14:07:39

00041514179TRLO0-1

10000

75

Euronext Dublin

14:24:03

00041514541TRLO0-1

2000

74.88

Euronext Dublin

14:38:32

00041515062TRLO0

2000

74.92

Euronext Dublin

16:11:41

00041518160TRLO0

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
POSTFBRTMTMMBLJ
Date   Source Headline
1st Sep 202210:08 amRNSTotal Voting Rights
30th Aug 20222:02 pmRNSKerry Acquisition Announcement
2nd Aug 202210:09 amRNSDirector/PDMR Shareholding
2nd Aug 20229:00 amRNSTotal Voting Rights
29th Jul 20227:00 amRNSKerry Group Interim Management Report 2022
1st Jul 20228:54 amRNSBlock listing Interim Review
1st Jul 20228:40 amRNSTotal Voting Rights
20th Jun 202210:23 amRNSHolding(s) in Company
1st Jun 202210:03 amRNSTotal Voting Rights
3rd May 202212:57 pmRNSTotal Voting Rights
28th Apr 20224:32 pmRNSDirectorate Change
28th Apr 20224:29 pmRNSResult of AGM
28th Apr 20227:00 amRNSQ1 Interim Management Statement 2022
4th Apr 20221:42 pmRNSStatement re Russian and Belarus Operations
1st Apr 202211:22 amRNSTotal Voting Rights
25th Mar 202212:55 pmRNSNotice of AGM
16th Mar 20221:50 pmRNSHolding(s) in Company
16th Mar 20221:39 pmRNSDirector/PDMR Shareholding
15th Mar 20224:45 pmRNSDirector/PDMR Shareholding
11th Mar 20224:03 pmRNSDirector/PDMR Shareholding
11th Mar 20223:59 pmRNSDirector/PDMR Shareholding
11th Mar 20223:55 pmRNSDirector/PDMR Shareholding
11th Mar 202212:13 pmRNSAnnual Financial Report
1st Mar 20229:50 amRNSTotal Voting Rights
25th Feb 20223:14 pmRNSDirector/PDMR Shareholding
16th Feb 20227:00 amRNSPreliminary Statement of Results 31 December 2021
15th Feb 202211:29 amRNSNotice of Results and AGM
15th Feb 20227:00 amRNSKerry – strategic biotechnology acquisitions
1st Feb 20222:21 pmRNSTotal Voting Rights
4th Jan 20223:00 pmRNSBlock listing Interim Review
4th Jan 202212:00 pmRNSTotal Voting Rights
13th Dec 202110:31 amRNSDirectorate Change
9th Dec 202112:17 pmRNSDirector/PDMR Shareholding
1st Dec 202112:26 pmRNSTotal Voting Rights
29th Nov 20211:28 pmRNSDirector/PDMR Shareholding
24th Nov 20215:41 pmRNSKerry - EUR750m Sustainability-Linked Notes
1st Nov 202111:20 amRNSTotal Voting Rights
27th Oct 20217:00 amRNSQ3 Interim Management Statement 2021
13th Oct 20217:00 amRNSKerry Strategic Update – Capital Markets Day
1st Oct 20219:20 amRNSTotal Voting Rights
27th Sep 20217:00 amRNSKerry Completes Sale of Meats & Meals Business
14th Sep 20217:00 amRNSKerry completes acquisition of Niacet
2nd Sep 202111:54 amRNSHolding(s) in Company
1st Sep 202111:22 amRNSHolding(s) in Company
1st Sep 202111:02 amRNSTotal Voting Rights
18th Aug 20214:11 pmRNSDirector/PDMR Shareholding
6th Aug 20214:20 pmRNSHolding(s) in Company
3rd Aug 202111:17 amRNSTotal Voting Rights
30th Jul 20217:00 amRNSKerry Group Interim Management Report 2021
8th Jul 20217:00 amRNSResult of public tender offer for Biosearch Life

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.